| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Intensity Therapeutics, Inc. A clinical stage biotechnology company whose mission is to create safer and more efficacious cancer therapies. Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected … Type: | 3 | 1 | 2 | 13 |
 | Ecovative - the mycelium technology company We grow better materials. Ecovative uses biology to solve fundamental human needs at industrial scales and in consumer applications. Ecovative uses mycelium to grow category defining products ranging from leather like textiles to sustainable packaging to high performance foams for apparel and beauty. Ecovative has been widely recognized for its technical and environmental contributions by organizations like the World Economic Forum and in the media including Wired Magazine, Forbes, and Time. Bio-Materials, Insulation, Packaging, Composite Boards, Compostable Materials, Mycelium, Textiles, and Mycelium Composites Type: | 30 | 9 | 19 | 94 |
 | Arcturus Therapeutics A global mRNA medicines and vaccines company Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a commercial mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR® mRNA Technology (sa-mRNA) and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus developed KOSTAIVE®, the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine in the world to be approved. Arcturus has an ongoing global collaboration for innovative mRNA vaccines with CSL Seqirus, and a joint venture in Japan, ARCALIS, focused on the manufacture of mRNA vaccines and therapeutics. Arcturus' … Type: | 5 | 1 | 3 | 207 |
 |  Joyn Bio Engineering better microbes for agriculture. Now a part of Ginkgo Bioworks. Joyn Bio is now a part of Ginkgo Bioworks! Learn more at https://www.ginkgobioworks.com/2022/10/18/ag-biologics-division-bayer-joyn/. Type: | 5 | 3 | 3 | 9 |
 |  Casebia Therapeutics An innovative gene editing company discovering and developing curative treatments for genetic diseases Bayer and CRISPR Therapeutics have entered into an agreement to create Casebia to discover, develop and commercialize new breakthrough therapeutics to cure blood disorders, blindness, and congenital heart disease. CRISPR Therapeutics will contribute its proprietary CRISPR-Cas9 gene-editing technology and intellectual property, while Bayer will make available its protein engineering expertise and relevant disease know-how. It is the first long-term strategic partnership of its kind to make a substantial investment in the development of target delivery systems in an effort to bring systemic in vivo CRISPR-Cas9 gene editing … Type: | 0 | 0 | 0 | 1 |
 | Silverberry Health Transforming healthcare, one patient at a time! Silverberry Health is a pioneering precision health platform that empowers clinicians and patients to use AI and achieve better health outcomes. Genomics, DNA Test, DNA Health, DNA Wellness, weight management, and Longevity Type: | 0 | 0 | 0 | 5 |
 | Knip Our mission: Drive farm profitability through improved feed performance while contributing to a food-secure future. We are Knip (formally KnipBio), a women-led biotechnology company based in Boston, pioneering advanced nutritional solutions for animal feeds. Using a naturally occurring microbe, our precision feed ingredients are sustainably produced without reliance on arable land and minimal water use. aquaculture, agriculture, synthetic Biology, fermentation, and blue economy Type: | 3 | 1 | 3 | 4 |
 | mobius There's Wonder in Waste. At mobius, we're creating a world where There’s Wonder in Waste. We’re a mission-driven company focused on eliminating waste by leveraging industrial organic waste streams from agriculture, forestry, paper and biofuel & biorefining industries to create new materials and chemicals. Our first product is a proprietary, biodegradable polymer made from lignin, a natural material found in all grasses and trees that is produced as waste at a rate of over 50 million tons each year by the paper and biofuel industries. With this biopolymer, we are creating a bio-based, biodegradable plastic pellets for applications in horticulture, … Type: | 0 | 0 | 0 | 2 |
 | BrainCo Inc BrainCo is a Brain-Machine Interface (BCI) company dedicated to bringing new brain-connected technologies to market. BrainCo’s leadership draws on deep experience in neuroscience research and expertise in education to deliver entirely new applications of brainwave technology in the education, wellness, and research spaces. We’ve learned important lessons as we’ve grown from a small team in an apartment basement to over 100 employees in 4 offices around the world. Since 2015 we’ve been working on providing the best experience possible for our customers and we’re here to share our progress and innovations with you. Brain-Machine Interface Technology, Focus Level Enhancement, Brainwave … Type: | 3 | 1 | 2 | 93 |
 | Atomwise Better Medicines Faster Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over … Type: | 13 | 4 | 7 | 43 |
 | Molecular Templates Engineering the Next Generation of Therapeutics Molecular Templates, Inc. (MTEM) is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform with unique mechanisms of actions which are highly differentiated from antibody drug conjugates (ADCs). MTEM is developing MT-6402, which is in a Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients; MT-5111, which is in a Phase I clinical trial for the treatment of HER2-positive cancers; and MT-0169, … Type: | 1 | 1 | 0 | 43 |
 | DrugDev DrugDev is an IQVIA company. DrugDev, an IQVIA company, is an innovative technology company which provides cloud-based solutions to help sponsors, CROs and investigators do more clinical trials together. Built around the largest global network of active opted-in investigators, DrugDev’s unified solutions suite optimizes site selection and startup, investigator payments and clinical operations. DrugDev also serves as the trusted third-party host of the revolutionary Investigator Databank collaboration and powers the TransCelerate Investigator Registry. Site Identification, Protocol Feasibility, Building Investigator Communities, Study Startup, Investigator Payments, Contracts and Essential Site Documents, Investigator Budget Development, and Software Type: | 0 | 0 | 0 | 72 |
 | Blueprint Medicines Striving to improve and extend patients' lives Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our … Type: | 10 | 1 | 6 | 731 |
 | C4 Therapeutics, Inc. Clinical-stage biotech company transforming how disease is treated through targeted protein degradation science C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve … Type: | 7 | 3 | 5 | 127 |
 | Catalia Health Mabu Care Insights Platform, there for patients in moments that matter. Catalia Health brings together artificial intelligence, psychology, and medicine to deliver durable patient engagement. Our programs deliver effective patient engagement and generate unique data captured through unique daily conversations with patients. Our Mabu Care Insights Platform delivers unique AI conversations to patients to help address their ongoing healthcare issues in an effective way. These messages are delivered through our uniquely engaging (and patented) interactive robotic coach named Mabu. Our customers are major pharma specialty brands that are hoping to help patients. We replace annoying phone call approaches with an … Type: | 11 | 1 | 4 | 5 |
 | Akili Welcome to Akili! At Akili, we believe there is potential for medicine to be developed, delivered and experienced in a completely different way. We’re bringing together world-class neuroscience with exceptional creativity and video game development to challenge the status quo of medicine. Our digital medicine is not delivered through a pill, but rather through a patented and captivating video game experience. Effective medicine that’s captivating and enjoyable to use – now that’s refreshing! We're continuously evaluating new technologies and are advancing a broad pipeline of programs to treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and … Type: | 11 | 2 | 8 | 123 |
 | AgBoost Data has a story to tell, we give it a voice. Agric-Bioformatics, INC is a technology company designed for the livestock industry. Our goal is to analyze, manage and improve performance and genomics data. Our cloud based Platform AgBoostTM will process and streamline data for selective breeding, health, market value and nutrition management. We aim to provide livestock producers an affordable, easy-to- use tool that allows for better access to, and understanding of, genomic information. Agric- Bioformatics will revolutionize the industry by determining market value of herd from an early age; providing for better breeding, enhanced nutrition management, and organization … Type: | 0 | 0 | 0 | 5 |
 | GENOSKIN Redefining Non-Clinical Research with Live Human Skin Genoskin brings unparalleled expertise in skin biology and immunology to advance your research and drug development efforts. Our mission is to provide reliable human data before regulatory studies for human therapeutics, vaccines, medical devices, cosmetics, and chemicals. Using natural human skin obtained through donations, we keep the skin alive for up to seven days post-surgery with a proprietary patented technology—enabling a full week of testing across all cell types and skin structures. Unlike animal or engineered models, our platforms offer authentic, human-relevant data. Supported by advanced assays, from imaging techniques to next-generation sequencing, … Type: | 19 | 7 | 10 | 44 |
 | ReviveMed AI-based Metabolic Platform for Precision Medicine ReviveMed, an MIT spinout, is an AI-driven metabolomics platform for precision medicine. Our patented technology detects 20x more metabolites per patient than traditional methods, enabling the creation of digital metabolic twins. Digital metabolic twins are virtual patient models representing individuals’ metabolic networks within a multi-omic context to simulate health and disease. We have a pipeline of metabolic twins for oncology and cardio-metabolic diseases, such as renal cell carcinoma, MASH, and obesity. Our metabolic twins increase trial success rates by predicting which patients respond to drugs and reducing trial sizes by simulating disease progression in … Type: | 3 | 3 | 1 | 5 |
 | Owkin We use AI to find the right treatment for every patient. Owkin is an AI biotechnology company that uses AI to find the right treatment for every patient. We combine the best of human and artificial intelligence to answer the research questions shared by biopharma and academic researchers. By closing the translational gap between complex biology and new treatments, we bring new diagnostics and drugs to patients sooner. We use AI to identify new treatments, de-risk and accelerate clinical trials and build diagnostic tools. Using federated learning, a pioneering collaborative AI framework, Owkin enables partners to unlock valuable insights from … Type: | 74 | 35 | 43 | 470 |
 | Orig3n COVID-19 testing, Wellness DNA Testing, Personalized Vitamins, and Regenerative Medicine Orig3n received Emergency Use Authorization clearance for their COVID-19 test on April 10, 2020. In addition to continuing work to provide the world with more knowledge about themselves based on their DNA, Orig3n is providing much needed COVID-19 capacity to nursing homes, boarding schools, clinicians, and underserved communities across the country. Orig3n helps people understand the links between their genes and how their minds and bodies work. From fitness to nutrition to personality, our DNA tests provide easy, affordable access to genetic information and guidance on how to use it. … Type: | 11 | 1 | 10 | 11 |
 | NGM Biopharmaceuticals Explorers on the frontier of life-changing science. NGM Bio is a biopharmaceutical company focused on discovering and developing novel, life-changing medicines for people whose health and lives have been disrupted by disease. The company’s biology-centric drug discovery approach aims to seamlessly integrate interrogation of complex disease-associated biology and protein engineering expertise to unlock proprietary insights that are leveraged to generate promising product candidates and enable their rapid advancement into proof-of-concept studies. As explorers on the frontier of life-changing science, NGM Bio aspires to operate one of the most productive research and development engines in the biopharmaceutical industry. All therapeutic candidates … Type: | 2 | 1 | 2 | 157 |
 | AgroSpheres A Future Built By Nature’s Technologies AgroSpheres is transforming agriculture through reliable and affordable biobased solutions. Biotechnology and Biological Engineering Type: | 14 | 3 | 2 | 31 |
 | Kaleido Biosciences We are unyielding in our pursuit of life-changing therapies and our grit and compassion lead us to fight for a better future for patients and their families. We believe there is tremendous potential in the area of targeting the immune system through the gut microbiome. By working with the microbiome rather than replacing it, Kaleido is in a unique position to unlock an untapped area of science with unprecedented new treatments. | 3 | 1 | 2 | 11 |
 | AgeX Therapeutics, Inc. AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targeting human aging. AgeX Therapeutics, Inc. (“AgeX”) is a biotechnology company focused on the emerging field of interventional gerontology. Its technology platform is built upon a modern understanding of the molecular basis of cellular immortality and regenerative biology. Leveraging technology licensed from parent company BioTime, Inc. as well as Geron Corporation, AgeX is leading the development of novel therapeutics targeting some of the largest market opportunities associated with an aging population. Type: | 0 | 0 | 0 | 12 |
 | UNITY Biotechnology UNITY is harnessing pathways of aging biology to develop new medicines, with a focus on retinal diseases. As pioneers in cellular senescence, UNITY is advancing the first senolytic therapeutic candidate for retinal diseases that aims to restore diseased tissue to a healthier state, a potentially paradigm shifting treatment in ophthalmology. Type: | 2 | 1 | 1 | 32 |
 | Inscopix, Inc. A New Approach to Understanding and Healing the Brain Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo … Type: | 8 | 2 | 6 | 67 |
 | APOLO Biotech Developing RNA's technologies Development of RNA-based technologies to enhance the productivity of crops (mainly intensive) which are respectful towards the environment and human health. Our OGM-free technology allows us to immunize crops against specific pathogens (fungi, insects, viruses), as a sort of "vaccine". In addition, we know how to modulate crop development, its response to the environment or the accumulation of metabolites of interest by designing RNAs as exogenous bioactive molecules to modulate the activity of plant genes. Fruits, Biotech, RNA, ARN, Plants, Vegetables, and Crops Type: | 2 | 0 | 2 | 28 |
 | BigHat Biosciences BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases. BigHat is backed by Section 32, Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids … Type: | 20 | 0 | 20 | 110 |
 | Paige Bridging Vision & Precision Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options. Learn … Type: | 10 | 1 | 6 | 95 |
 | MDClone Unlock healthcare data. Transform care. See #syntheticdata in action. See an ADAMS Platform demo today: Link in bio MDClone offers an innovative, self-service data analytics environment powering exploration, discovery, and collaboration throughout healthcare ecosystems, cross-institutionally, and globally. The powerful underlying infrastructure of the MDClone ADAMS Platform allows users to overcome common barriers in healthcare in order to organize, access, and protect the privacy of patient data while accelerating research, improving operations and quality, and driving innovation to deliver better patient outcomes. Unlike traditional analytics platforms, the MDClone ADAMS Platform introduces a fundamentally different approach to healthcare data analysis, exploration, and … Type: | 2 | 0 | 1 | 128 |
 | Enveda Learning from life Enveda is a biotechnology company that is learning from life’s chemistry to create better medicines faster. Enveda uses AI-powered tools to identify and characterize a wide range of molecules produced by living organisms—the vast majority of which have never been explored by science—creating a database of chemical biodiversity: the library of life. By growing, organizing, translating, and searching this unique library, Enveda learns from life’s evolved solutions to address today’s pressing medical needs. For more information on Enveda, visit enveda.com. Type: | 7 | 0 | 7 | 249 |
 | Generate:Biomedicines Pioneering generative biology to create breakthrough therapeutics. Pioneering generative biology to create breakthrough therapeutics. Type: | 14 | 0 | 13 | 324 |
 | Ranomics Ranomics offers innovative solutions for protein engineering, drug discovery, genomics research and synthetic biology Ranomics offers high throughput solutions for protein engineering, drug discovery, genomics research and synthetic biology. Using our VariantFind and VERG genomics platforms, Ranomics offers partners the a scalable solution to engineer and screen genetic variants in a wide range of model organisms. Our industry leading DNA Variant libraries and high-throughput cell assays help researchers to hit their research objectives faster and with better results than traditional methods. Over the years, we have worked with top biotech and pharma companies in the US and worldwide. Our partners … Type: | 0 | 0 | 0 | 5 |
 | OPPI India Partnering India since pre-independence to improve patient safety & provide healthcare access to all. #BharatKeLiye The Organisation of Pharmaceutical Producers of India (OPPI) was established in 1965 and represents the research-based pharmaceutical companies in India. OPPI remains committed to supporting the nation’s healthcare objectives and collaborating with all stakeholders to find sustainable solutions. OPPI believes the need for innovation must be balanced with the necessity for more accessible medicines, within a robust IP environment. Vision: OPPI is an organisation of research and innovation driven pharmaceutical companies committed to addressing India's healthcare needs by: - Facilitating greater access to quality healthcare … Type: | 18 | 2 | 18 | 18 |
 | The Trendlines Group Succeeding together The Trendlines Group invests in innovations in agrifood and medtech, leveraging our experience, partnerships network, and resources to go from seed to market. Trendlines’ shares are traded on the Singapore Stock Exchange (SGX: 42T) and in the United States as an American Depositary Receipt (ADR) on the OTCQX International (OTCQX: TRNLY). High Tech, Investment, Agritech, Venture Capital, agtech, healthcare, agrifoodtech, lifesciences, medtech, and agrifood Type: | 18 | 1 | 17 | 25 |
 | DNA TraceBack® When we don't know where our food comes from, it can be hard to build transparency and trust in your meat and seafood brands. DNA TraceBack® uses nature’s barcode (DNA) to provide traceability for the verification of origin and associated production claim for meat and seafood products- from fork to farm. We help leading food organizations to market their brands with greater confidence, so they can openly share the story of where their food comes form and how the animals involved were raised. | 4 | 1 | 3 | 39 |
 | BrainCheck Digital cognitive care – anytime, anywhere BrainCheck is a digital health company powering positive progress in cognitive health. The BrainCheck PlatformTM offers the most comprehensive digital cognitive toolset to promote proactive screening, detect early signs of decline, and personalize care planning – anytime, anywhere. Founded by renowned neuroscientists and technologists, including David Eagleman, PhD, our intuitive solutions transcend the limitations of traditional methods and expand access to cognitive care with the tap of a finger, from any device, in any location. Trusted by hundreds of leading providers and healthcare systems, our clinically-validated digital cognitive assessment and care planning tools fit … Type: | 5 | 1 | 5 | 57 |
 | Kernal Biologics KernalBio creates mRNA therapies that instruct specific cells on how to make their own medicine Kernal creates mRNA therapies to cure severe diseases including cancer. Our mRNA therapies instruct specific cells on how to make their own drugs. With roots at MIT, Harvard and Big Pharma, our team previously built a successful Biotech company and has deep expertise in mRNA space. synthetic biology, RNA design, immunotherapy, covid-19, cancer, and mRNA therapy Type: | 10 | 2 | 4 | 15 |
 | Poolbeg Pharma plc Focused on the development & commercialisation of innovative medicines. Ticker: POLB Poolbeg Pharma plc is focussed on the development and commercialisation of innovative medicines targeting serious diseases with a high unmet medical need. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to support the growth of the Company and the development of its robust pipeline of innovative products, thereby driving significant value creation. Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value. The team has been strengthened by the appointment of three former members of the … Type: | 7 | 0 | 7 | 15 |
 |  Pharvaris Pioneering science for patient choice Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and other bradykinin-mediated diseases. The company brings together executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically … Type: | 0 | 0 | 0 | 117 |
 | Mainz Biomed Saving lives through innovative molecular diagnostic solutions. Mainz Biomed is aiming to become a leading provider of easy-to-use diagnostic solutions for patients everywhere. We develop innovative products that quickly and easily identify the early onset of several leading deadly conditions including colorectal and pancreatic cancers. Visit our website www.mainzbiomed.com to learn more about our company and our mission to save lives through science. molecular genetic in-vitro diagnostics | 1 | 0 | 1 | 46 |
 | Berlin Heals Holding AG Cardiac Microcurrent C-MIC - A novel therapy for chronic heart failure Berlin Heals is a Start-up-Company in Berlin, Germany. We are devoted to the treatment of heart failure. We will redefine heart failure treatment with a novel device that is capable of healing the heart. Contact us at info@berlinheals.de to get in touch with us. Get more Information here: www.berlinheals.de R+D and Marketing of a novel cardiovascular device Type: | 0 | 0 | 0 | 30 |
 | Addicted2Success This Website Will Change Your Life Our mission at Addicted2Success is to empower and inspire people by spreading knowledge of self development and life changing stories to the world. We show you what it really takes to become a successful human being. With new motivational videos, interviews, audio and more with your favourite entrepreneurs, life coaches, celebrities and inspirational people from all over the world. Type: | 1 | 0 | 0 | 25 |
 | Multiple Myeloma Research Foundation - MMRF Accelerating a smarter, faster, cure for mutiple myeloma. We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives. Central to our mission is our commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. Since our inception, the MMRF has committed over $500 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy … Type: | 7 | 4 | 7 | 116 |
 | Capsugel Follow us at Lonza Capsules & Health Ingredients Follow us on our Lonza Capsules & Health Ingredients LinkedIn page. Lonza's Capsules & Health Ingredients business is the trusted business partner in innovative capsules, dosage form solutions and health ingredients for pharmaceutical and health and nutrition companies. Our reputation for capsule expertise and science-backed ingredients has connected 5,000 global customers, who ultimately enable hundreds of millions of patients and consumers to live a healthier life. CHI has its roots from legacy Lonza ingredients united with two Lonza acquisitions, Capsugel and InterHealth Nutraceuticals. Hard & Soft Capsule Manufacturing Type: | 2 | 1 | 0 | 941 |
 | MICROTRAC A leader in Particle Characterization | Part of Verder At Microtrac, we have a passion for making particle analysis accurate, effective, and convenient to exceed customer expectations. MICROTRAC is a technology leader, committed to innovation, with an extensive global network and an unrivaled offering in particle characterization. Our centers of excellence in Germany, the USA, Japan, and France, allow us to provide our customers with the best analytical instruments for R&D, Quality Control and Product Development. We offer an unrivalled range of particle characterization technologies! Particle Size Analysis, Surface Area Analysis, 3D Image Analysis, Process Control, and Contract Lab Services | 3 | 0 | 2 | 100 |
 | Department of Computer Science, University of Oxford University of Oxford Department of Computer Science’ news on our outstanding computer science research #compscioxford Department of Computer Science at the University of Oxford 7 times ranked top university in the world for computer science #compscioxford Our mission is to be an internationally leading centre of research and teaching across a broad spectrum of computer science, ranging from foundational discoveries to interdisciplinary work with real-world impact in computational biology, quantum computing, computational linguistics, information systems, software verification to software engineering. The department is home to undergraduates, full-time and part-time Master's students, and has a strong doctoral programme. We are proud … Type: | 15 | 1 | 10 | 164 |
 | Oxford Drug Design A drug-discovery company focused on oncology. Follow us on Twitter @OxDrugDes Oxford Drug Design, an advanced spinout from Oxford University, is an innovative biotechnology company discovering and developing novel therapeutics supported by pioneering computational methods. We design innovative drugs with differentiated modes of action against cancer and other challenging diseases with high unmet medical need seeking superior patient outcomes. Based on the unique integration of our dual core competences in aminoacyl-tRNA synthetase enzymes and distinctive AI/ML methods, our pipeline expansion is focused on oncology. This distinctive drug discovery platform has been validated by the rapid discovery of novel therapeutic candidates … Type: | 5 | 1 | 3 | 10 |
 | Synairgen plc We are a specialist respiratory biotech company focused on severe viral lung infections Synairgen is a specialist respiratory biotech company whose primary focus is developing its investigative inhaled IFN-β candidate for the treatment of severe viral lung infections as potentially the first host-targeted broad-spectrum antiviral treatment delivered directly into the lungs. Founded by University of Southampton (UK) Professors Sir Stephen Holgate, Donna Davies and Ratko Djukanovic in 2003, Synairgen is quoted on AIM (LSE: SNG). For more information, please visit www.synairgen.com. Type: | 4 | 1 | 1 | 25 |
 | Source BioScience Industry-leading provider of Genomic and Histopathology services, including Cellular & Digital Pathology. Source BioScience, comprised of Source LDPath and Source Genomics, provides industry-leading laboratory services in Genomics and Histopathology, partnering with biotechnology, pharmaceutical, healthcare and academia. Source LDPath provides an end-to-end clinical diagnostic service, from histopathology, including digital pathology and AI, through to molecular diagnostic services. Source LDPath already supports over 85 NHS Trusts and a comprehensive network of Private Healthcare clinics to expand their diagnostic capabilities, ensuring diagnostic results are delivered within clinically actionable timeframes. Source LDPath brings pioneering expertise in digital pathology and AI implementation, helping NHS pathology … Type: | 8 | 0 | 5 | 202 |
 | The Institute of Cancer Research Making the discoveries that defeat cancer. The Institute of Cancer Research is making the discoveries that defeat cancer. In addition to being one of the world's most influential cancer research organisation, we are also a postgraduate college (a member of the University of London), and a charity. Our outstanding record of achievement dates back more than 100 year and together with our hospital partner, The Royal Marsden NHS Foundation Trust, we are rated in the top four centres for cancer research and treatment worldwide. Cancer Research, Training, Genomics, Immunotherapy, Imaging, Genetics, Teaching, Education, Industry partnerships, Fundraising, and Drug discovery Type: | 12 | 1 | 7 | 1,493 |
 | Wellcome Trust Centre for Human Genetics, University of Oxford The Wellcome Trust Centre for Human Genetics (WTCHG) was established in 1994 to undertake research into the genetic basis of common diseases. Since June 1999 the Centre has been located in the Henry Wellcome Building of Genomic Medicine, University of Oxford. The scientific objective of the Centre is to explore all aspects of the genetic susceptibility of disease including the localisation of genes involved in common diseases, characterisation of the variants responsible for susceptibility, the understanding of how these DNA variants may contribute to risk of disease in the population and finally, how such genetic factors contribute biologically to a … Type: | 1 | 0 | 0 | 98 |
 | MycoNourish Harnessing the power of beneficial fungi to enhance crop production and adding value for growers. MycoNourishTM harnesses the power of beneficial microbes known as ‘arbuscular mycorrhizal fungi’ to improve crop production. Our microbes are completely natural fungi that live underground. Working in symbiosis with plants, they act as a secondary root system, increasing plant health and improving the quantity and quality of crop yields. These fungi are a natural part of crop production systems, forming relationships with most crops, and are present in the majority of production systems. However, the mycorrhizal fungi that are already present in these systems have … Type: | 0 | 0 | 0 | 5 |
 | KeyGene The crop innovation company KeyGene is the go-to research company developing and applying technology innovation for crop improvement, for and with partners. With our intellectual capital, solution driven approach and collaborative spirit, we work for the future of global agriculture with partners in the AgriFood sector. Using our proprietary technologies, we support customers with the development of new and improved crops. Our goal is to support organizations with their toughest R&D challenges, combining our cutting edge breeding technologies, bioinformatics & data science expertise and trait technologies. KeyGene was founded in 1989 by a number of Dutch seed companies. The company … Type: | 10 | 1 | 7 | 137 |
 | Breast Cancer Haven Breast Cancer Haven has suspended all live services. Please check our website for updates. As of the 30th June 2021 Breast Cancer Haven has suspended all live services. However, we still have a lot of useful information to support you. Please visit our website for information, videos and audio support. complementary therapies, support, individual consultation, stress reduction programme, yoga, nutrition, comfort, relaxtion, breast cancer, and charity | 10 | 1 | 10 | 27 |
 | Transgene Immunotherapy against cancer. 4 clinical-stage products. 2 novel platforms: Invir.IOTM and myvac® Cancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer. | 26 | 14 | 11 | 206 |
 | Porsolt - Preclinical CRO Scientist-to-Scientist 🔬 Porsolt is a long-established preclinical CRO, accredited by AAALAC and fully GLP compliant. 👨🏻🔬 With our Scientist-to-Scientist approach we support you at every step of the preclinical development process, providing the best scientific advice and offering tailored solutions to meet your needs. ✔️ We have a recognized international reputation for in vitro, ex vivo, and in vivo expertise in physiopathological models, customized procedures, histology, biomarkers, and tailored solutions for discovering treatments in over 10 different therapeutic areas. ✔️ We also offer services for safety evaluation of drug candidates from screening to pre-Phase 1 regulatory studies (ICH S7), in … Type: | 4 | 1 | 4 | 86 |
 | In-Cell-Art In-Cell-Art, is a biopharmaceutical company specializing in the preclinical and pharmaceutical development of solutions (DNA/RNA based vaccines or therapeutics) treating acquired or inherited diseases using patented bioinspired synthetic delivery systems (named Nanotaxi®) consisting of different chemical families (lipids, polymers). Its founder and research team, which includes a Nobel Laureate, have developed this unique intellectual property expertise and know-how based on 20 years of research in the field of supramolecular nucleic acids transfection agents. The vaccines and therapeutics developed by In-Cell-Art have been validated by numerous studies using infectious disease models (HIV, Flu, Dengue, dust mite, mycobacterium abscessus), therapeutic cancer models … Type: | 0 | 0 | 0 | 1 |
 | EXTRACTIS Experts in #plant #biorefinery, #innovative #process #engineering, #extraction, #processing, #production, #scale-up EXTRACTIS is a service provider specializing in the field of extraction, fractionation and chemistry of plant biomass for the development of new innovative products/processes. 2 main activities: Research and Development under contract with processes adapted to the markets and in line with the issues and constraints of our customers on all types of plant raw materials, co-products or fractions using in particular innovative technologies (Ultrasound, Membrane Electrodialysis, reactive extrusion, subcritical water, etc.) Transfer and shaping: the service platform dedicated to the design of turnkey projects from the laboratory to … Type: | 22 | 5 | 7 | 13 |
 | BIOTEM First Class Antibodies & Immunoassays Your partner in immunotechnologies since 1980! Our commitment makes the difference! Expert in immunotechnology, BIOTEM is a contract Research Organisation which complies with ISO 9001:2008 quality standards. Since its establishment in 1980, the company has been the privileged partner of prestigious industrial and academic laboratories for their R&D, diagnostic and therapeutic projects. Based on a high level of expertise and exclusive technologies, BIOTEM implements the most relevant strategies for each project and is pledged to achieve the results outlined in the contract. BIOTEM advantages: - Results guaranteed - An unparalleled traceability throughout your project - Optimal quality of your product … Type: | 17 | 4 | 15 | 39 |
 | ALIOS Conseil - ALIOS recrute!! ALIOS Conseil is a CRO created in 1995 and specialized in providing experts to the health industries (Pharmaceutical, Medical Device and Cosmetic) Our consulting offer is structured around our 5 departments: Clinical Research, Health Product Vigilance, Medical Affairs, Regulatory Affairs and Quality Assurance. Our objective: meet your needs and support you on your issues ALIOS CONSEIL is: - A tailor-made, fast and efficient response - Motivated, experienced and supported employees throughout their intervention - Transparency for our customers and employees Contact: Website: www.aliosconseil.com Email: aliosconseil@aliosconseil.com Tel. : 07 88 81 64 52 Provision of employees, Management Consulting, Clinical Research, Regulatory … Type: | 1 | 0 | 1 | 4 |
 | Alpha MOS Sensory Analysis Solutions Alpha MOS offers reliable and fast solutions that can control the sensory quality of their products and secure their manufacturing processes. The company specializes in sensory analysis instrumentation and is the worldwide leader of smell, taste and visual industrial analyzers: so-called electronic nose, electronic tongue and electronic eye. It has more than 1000 instruments installed worldwide for Food, Beverage and Packaging industries. First company to market electronic noses, Alpha MOS has always made strong investments in R&D to develop innovative products that would meet the needs not fulfilled that far. Several developments about systems and methods for … Type: | 3 | 1 | 0 | 64 |
 | GenoScreen Genoscreen provides genomic services and innovative solutions in genomics. Created in 2001, GenoScreen is an innovative company specialized in the field of genomics. Using cutting-edge technologies, it analyzes and interprets information encoded in DNA to provide tailored solutions for healthcare, environment, agronomy & agriculture, agri-food, skincare, etc. Unlock the power of DNA: • Services in molecular biology analyses (DNA sequencing, genotyping, detection of gene mutation, metagenomics analysis in complex environment...) • Targeted deep sequencing-based kits for culture-free microbial diagnosis • Expertise and consultancy services for companies which develop projects in genomics GenoScreen also proposes custom-made trainings to people wishing to … | 11 | 6 | 5 | 39 |
 | Laboratoire Traitement du Signal et de l’Image (LTSI) LTSI research is at the interface of disciplines in the fields of information science and technology and health. Its aims are methodological, technological and clinical and its finalities are interpretation and decision support. It is structured around the core ‘signal-model-image’, these three components providing essential added value. The work is carried out within five teams. Each team is focused on a specific target and is made up of a multidisciplinary group capable of integrating the most recent physiological knowledge in the field into its approach and identifying the underlying methodological issues. The work of the CINETYKS team concerns the dynamics … Type: | 9 | 1 | 1 | 70 |
 | Département Sciences Biologiques et Médicales Composed of 11 research units and 1 service unit focused on understanding the fundamental mechanisms of the cell, physiology and pathophysiology, the Biological and Medical Sciences department works to develop innovations that will shape the medicine of tomorrow. cancer, rare diseases, chronic diseases and immunities, microbiology, and cell biology Type: | 6 | 0 | 1 | 1 |
 | SIRIC Montpellier Cancer Site of excellence dedicated to the integration of medical, scientific and societal research in cancerology A site dedicated to research and innovation in cancerology The SIRIC Montpellier Cancer is one of the eight Integrated Cancer Research Sites accredited by the National Cancer Institute, and the only accredited site in the South of France. By mobilizing a community of excellence of multidisciplinary clinicians and researchers, our mission is to advance the understanding, prevention and treatment of cancer. An ecosystem of excellence The SIRIC Montpellier Cancer brings together: - 20 research teams covering biology, human and social sciences, mathematics, computer science and … Type: | 4 | 0 | 2 | 1 |
 | Biose Industrie Founded in 1951 by pharmacists and microbiologists, biose® has 60-year experience in drug based on live bacteria, giving us a deep understanding of the entire process from discovery to commercialization. Focused on Health through microbiota and microbiome science, we use our skills for the discovery, product development, clinical studies and manufacturing of Live Biotherapeutic Products (LBPs). Our company is drug-GMP certified for the manufacturing of bacteria-based APIs, clinical and commercial products. Microbiome Therapeutics, live biotherapeutics, LBPs, and CDMO Type: | 10 | 5 | 3 | 213 |
 | DBV Technologies On a mission to advance epicutaneous immunotherapy using our innovative technology platform, ViaskinTM DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively. We are on a mission to advance epicutaneous immunotherapy using our innovative technology platform, ViaskinTM, to develop treatment options for immunologic diseases with significant unmet medical need. This mission drives our commitment to the advancement of treatments for patients and their families. That is why we are investigating a potential new class of immunotherapy, epicutaneous immunotherapy (EPIT), that aims to re-educate the … | 5 | 3 | 0 | 194 |
 | PhysioStim Nonclinical expert in cardiovascular pharmacology & electrophysiology and vascular functions PhysioStim is a French preclinical CRO dedicated to cardiovascular pharmacology and electrophysiology from discovery stages to clinical development. Whatever the therapeutic areas, we ensure robust and valuable preclinical data on cardiac and vascular activities and secondary pharmacology to secure in-vivo development and bring new safe therapies to patients. Thanks to our predictive and translational models, we define the POC of drug discovery, we investigate secondary pharmacology with on and off-target liabilities, and we address the safety purpose to build and support your IND submission (with mandatory and not mandatory assays). … Type: | 2 | 0 | 2 | 10 |
 | Novalix Novalix is a premier drug discovery CRO Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Organic Chemistry, cryo-electron microscopy, Chemical development, Medicinal chemistry, Structural Biology, in vitro pharmacology, DNA-encoded libraries, Flow chemistry, and Chemical process research Type: | 36 | 6 | 32 | 373 |
 | Clean Cells Solution for biologics Clean Cells is a GMP-licensed Contract Development and Manufacturing Organization providing R&D, production and quality control testing services to the biopharmaceutical industry. Our two-part site located in Western France holds an innovative process development platform, BSL2 and BSL3 GMP manufacturing laboratories and analytical areas to develop bespoke assays and perform GMP testing. Clean Cells is part of the Clean Biologics group and benefits from the additional experience of sister company Naobios, a CDMO with considerable experience in the development and manufacture of virus-based products. biosafety testing, Cell Banking and Storage, Viral Clearance, Potency Assay, R&D Contract, Training, … Type: | 9 | 3 | 7 | 119 |
 | PolymerExpert Putting innovation first. Founded in 2000, PolymerExpert is a French company specialized in the field of polymers. Born from a passion for innovation, the company has become a major player in polymer research and development, particularly in the medical sector (implantable & non-implantable medical devices, biotechnologies, pharmaceuticals), the aeronautics, aerospace, defense sector (composite materials, energetic materials, lubrication), industrial sector (building, energy, sports) or the cosmetics sector (smart raw materials, make-up, skincare, solar). PolymerExpert has filed more than 65 patents and devotes 35% of its revenues to the development of new polymers. Today PolymerExpert keeps innovating in this field by mastering … Type: | 9 | 3 | 8 | 21 |
 | GENCLIS SA The Transcription Infidelity Technology GENCLIS SA is a privately-held French Biotechnology that discovered a unique biological mechanism referred as to Transcription Infidelity (TI). Transcription Infidelity is a newly discovered and patented mechanism that incresases RNA-DNA sequence divergences (RDD). TI can lead to base substitutions, insertions and deletions. The latter cause translational frameshifts that have important consequences in determining protein immunogenicity. Genclis currently focuses on defining the effects of TI proteins translated from gapped RNA on normal and pathological humoral immunity. Type: | 0 | 0 | 0 | 5 |
 | Provepharm Act to improve life An independent, international specialty pharmaceutical company, Provepharm leverages the potential of mature and well-known molecules to develop innovative solutions that improve patients' lives. Provepharm develops, manufactures, and markets a range of hospital products including antidotes and dyes. Notably, the company is recognized for its expertise in the endoscopic and surgical dye markets. Working closely with healthcare professionals, Provepharm is committed to developing specific services aimed at helping them enhance clinical practices. With a team of over 160 professionals and offices in France, the US and UK, the company markets its products in over 25 countries worldwide … Type: | 7 | 5 | 2 | 158 |
 | ELITechGroup - A Bruker Company ELITechGroup is a global leader in in-vitro diagnostics, serving hospitals and diagnostic laboratories in over 100 countries. The company develops, manufactures, and markets a comprehensive range of cutting-edge diagnostic products and solutions, including instruments, reagents, and software. To best meet the needs of its customers, ELITechGroup is organized into three specialized business areas, each dedicated to specific IVD technologies and market segments: Molecular Diagnostics (MDx), Biomedical Systems (EBS), and Microbiology (EM). With a global team of about 600 professionals, ELITechGroup is proud to be part of Bruker Corporation. Bruker’s science and technology leadership puts ELITechGroup’s solutions at the forefront of … Type: | 0 | 0 | 0 | 416 |
 | Aureus Pharma Aureus Sciences focuses on providing solutions to the needs of pharmaceutical and biotech companies to leverage information and knowledge as a decision making tool and to increase the speed and efficiency of their drug discovery and development process. Over the course of 10 years and with a significant investment, the Company has developed a unique Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases. Using this platform the Company provides best-in-class, scientific databases and associated software applications for use by researcher involved in the drug discovery and development process.The company's range of products includes … Type: | 0 | 0 | 0 | 2 |
 | SYNCROSOME - Cardiovascular Preclinical expert Cardiovascular & respiratory preclinical expertise since 2000 - ETAP-Lab's cardiology branch of services. At a glimpse SYNCROSOME is the cardiology branch of ETAP-Lab, French preclinical CRO dedicated to in vitro & in vivo efficacy studies for pharmaceutical & biotech companies for over 30 years. Range of services SYNCROSOME is dedicated to cardiovascular & respiratory diseases models like HFrEF, HFpEF, acute myocardial ischemia and arterial/pulmonary arterial hypertension... Models in cardiometabolic disorders are also available. Our added value We can accelerate, derisk and support preclinical development of therapeutics thanks to relevant & translatable in vitro and in vivo models. Our experts aim … Type: | 2 | 2 | 1 | 7 |
 | Theranica A new era in migraine therapy Theranica is a neuromodulation therapeutics company dedicated to creating effective, safe, affordable, and low-side-effect therapies for idiopathic pain conditions. Our initial focus is on migraine, one of the most common neurologic disorders affecting over 1 billion people, with a high prevalence and morbidity, especially among adolescents and females. The company’s award-winning flagship Nerivio® REN wearable is changing the game for migraine sufferers, especially the 100 million adolescents facing this complex and non-curable disease. Nerivio is the first and only REN wearable that harnesses the natural power of the brain to shut off migraine symptoms … Type: | 3 | 0 | 2 | 72 |
 | Ikan Biotech We are a biotech company, specialized in cancer research. Our technology allows us the development of avatars of cancer patients , using zebrafish. | 1 | 0 | 0 | N/A |
 | TolerogenixX GmbH The Smart Way to Immune Tolerance TolerogenixX vision is to innovate Immunosuppression with its newly developed MIC Cell Treatments. MIC Cell Treatment is a curative ATMP approach to achieve a sustained regulation of the immune system in Transplant - and Autoimmune Disease Patients. TolerogenixX has been able to generate strong pre-clinical as well as clinical data in the indications of Transplantation and Autoimmune Diseases e.g. SLE since its foundation in 2016. Type: | 0 | 0 | 0 | 3 |
 | Apoha Currently in stealth - we will reveal soon! Our team of scientists and product experts are on a mission: developing Sensory Intelligence to seamlessly anchor machines into physical reality. Exciting things are in the pipeline... Stay tuned! #SensoryIntelligence #FutureOfMachines | 3 | 0 | 2 | 23 |
 | NeuroID, a part of Experian Next-Gen Behavior & Device: Detect Fraud Anywhere User Interaction Occurs NeuroID is now proudly a part of Experian! NeuroID combines the power of industry-leading behavioral analytics with advanced device and network intelligence to create your first line of defense against malicious bots, bad actors, and fraud rings. Secure your entire user lifecycle with a single integration, stopping everything from ID theft to ATO fraud from the very first interaction. Real-Time Behavioral Analytics, Digital Body Language, Advanced Machine Learning, Neuroscience, FinTech, Fraud, InsurTech, Digital Customer, Behavioral Data, Human-Computer Interaction, Data Science, New Account Opening, Verification, Customer Journey, Digital Forms, Behavioral Analytics, … Type: | 2 | 0 | 2 | 42 |
 | LifeOmic Powering precision health, acquired by Fountain Life LifeOmic, a healthcare technology company, works with health care providers, researchers, and health-focused enterprises to aggregate and utilize health data to improve patient outcomes and provide valuable, actionable insights. The LifeOmic Platform goes far beyond storage. Our secure, cloud-based platform forms the technology backbone for aggregating and managing complex health data in oncology, cardiology, MedTech, Pharma and more. The user-friendly interface, configurable mobile app, real-time analysis and visualization and attribute-based access controls meet the needs of each individual or organization. With the LifeOmic Platform you can: - Easily Collect & Analyze Data to … Type: | 5 | 1 | 2 | 18 |
 | Stemcentrx, Inc. Founded in 2008, Stemcentrx combines state-of-the-art research and GMP manufacturing capabilities. This has allowed us to advance from target discovery in our laboratory to treating patients in clinical trials at an accelerated pace. We are investigating many of the largest and most lethal cancers through our proprietary platforms that identify cancer stem cells, discover novel targets, engineer and manufacture antibodies and antibody drug conjugates. Our mission is to develop therapies that cure and significantly improve survival for cancer patients. We are pioneering new approaches to eliminate cancer stem cells, which initiate and perpetuate tumors. Stemcentrx has assembled a talented and … Type: | 1 | 1 | 0 | 8 |
 | Basepaws Basepaws is a pet genetics company that creates affordable, easy-to-use health tests for every pet parent. Basepaws is a petcare genetics company that builds early detection health risk tests based on genetic and microbiome data. Basepaws is committed to companion animal health research, and it has the world’s first at-home genetic testing platform for cats. Founded in 2017 by Anna Skaya, the company is based in Los Angeles, CA. On June 22, 2022, Zoetis Inc. (NYSE:ZTS) announced the completion of its acquisition of Basepaws. The acquisition was first announced on June 7th, and the financial terms of the transaction were … Type: | 8 | 2 | 7 | 35 |
 | Halo Join a community of scientific experts working together to bring new innovations to the world Halo is a partnering platform that helps corporate R&D teams discover new technologies, build relationships with the researchers and startups behind them, and more efficiently scale external partnerships globally through the power of networks and AI. Since launching in January 2020, more than 7,000 universities from 135+ countries have joined the platform. In 2021, Halo was recognized as one of Fast Company's 2021 World Changing Ideas. On Halo, corporate R&D divisions post areas of interest for research collaborations (ie. Request-For-Proposals) and interested parties (scientists, startups, … Type: | 20 | 1 | 17 | 127 |
 | Veritas Genetics Veritas Genetics is now a LetsGetChecked company. For future updates on the combined entity, follow @LetsGetChecked. Clinical Diagnostics, Genetics, Whole Genome Sequencing, and Genomics | 3 | 0 | 3 | 33 |
 | Aratana Therapeutics Inc. Aratana Therapeutics is a wholly owned subsidiary of Elanco Animal Health. Aratana Therapeutics, Inc. (Nasdaq: PETX) is a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats. Our mission is to successfully develop and deliver best-in-class therapeutics, provide comprehensive service to veterinarians and serve as a collaborator of choice for human and animal health companies. We believe our therapeutics are highly differentiated, resolve recognizable needs in compelling markets and have therapeutic profiles superior to the standard of care. Our FDA-approved and commercially available therapeutics include: - A prostaglandin receptor antagonist that specifically targets … Type: | 2 | 0 | 0 | 16 |
 | Neurable Your mind. Unlocked. 🧠 The Mind. Unlocked. Work Smarter. Live Better. Through proprietary brain-computer interface (BCI) technology, Neurable is pioneering the future of human-computer interaction by allowing you to use the power of your brain to get more out of your everyday devices. Brain-Computer Interface, Machine Learning, Virtual Reality, Augmented Reality, and Neuroscience Type: | 9 | 3 | 4 | 43 |
 | Biofourmis Revolutionizing the Delivery of Healthcare. Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solution collects and analyzes over 120 biomarkers in real time and identifies shifts that require proactive interventions. This vital innovation enables Biofourmis to offer people everywhere connected access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes. Trusted by leading health systems, payers, biopharma companies and patients alike, Biofourmis’ connected platform improves patient outcomes, prevents hospitalization readmissions, accelerates drug development, and closes critical gaps in care—with the goal of making science … Type: | 34 | 3 | 31 | 312 |
 | Advamedica Inc. Biomaterials. Hemostats. Medtech Advamedica Inc. is a deep science medtech company focused on biomaterial based medical devices. Hemostats, Woundcare, and Biomaterials Type: | 0 | 0 | 0 | 3 |
 | Cocoon Biotech Cocoon Biotech, Inc., was founded in 2013 to bring the freedom of living a healthy productive life to patients worldwide. Cocoon Biotech is developing a drug-delivery platform based on formulations of fibroin, a protein derived from the cocoon of the silkworm (Bombyx mori). Recent advances in our understanding of fibroin biochemistry has allowed expansion of the versatility of the material into alternate physical formats such as hydrogels and implants loaded with active drug substances. Cocoon is leveraging silk fibroin as a novel biomaterial for the stability and delivery of therapeutics across human health and animal health. Cocoon’s first products are … Type: | 1 | 1 | 0 | 6 |
 | Outcomes® Outcomes® unites technology and clinical relationships through a connected healthcare network to drive better outcomes. As a leading patient-centric technology business, we unite pharmacies, payers, and pharmaceutical companies through patient engagement solutions, tailored tools for the future pharmacy, and advanced workflow optimization. Our comprehensive offerings benefit a nationwide network of 48,000 community, chain, and grocery pharmacies, and more than 70 million patients. Type: | 0 | 0 | 0 | 799 |
 | Biosortia, Inc. Unlocking the Hidden Chemistry of Microbiomes for Next-Generation Therapeutics with ISMM • Expanding Customer Pipelines Biosortia Pharmaceuticals is pioneering a revolutionary approach in drug discovery through its Industrial Scale Microbiome Mining (ISMM) technology. By accessing the vast, untapped chemical diversity found within natural microbiomes, We unlock a hidden world of small molecules that play crucial roles in cellular signaling and disease processes. These small molecules, often referred to as the "drug-like dark matter" of cellular biology, have been largely inaccessible until now. Our technology allows for the large-scale harvesting and exploration of these compounds, providing an unprecedented opportunity to discover … Type: | 1 | 0 | 1 | 10 |
 | Syros Pharmaceuticals By redefining the power of small molecules to control gene expression, we aim to provide a profound benefit for patients Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, Syros is developing tamibarotene, an oral selective RARα agonist in frontline patients with higher-risk myelodysplastic syndrome with RARA gene overexpression. For more information, visit www.syros.com and follow us on X (@SyrosPharma) and LinkedIn. | 7 | 2 | 4 | 58 |
 | OneChain Immunotherapeutics Development of CAR-T candidates for the treatment of acute lymphoblastic leukemia and other hematological malignancies. OneChain Immunotherapeutics is a spin-off Company from the Josep Carreras Leukemia Research Institute and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez. Biomedicina, CARTs, Inmunoterapia, Investigación, Biotecnología, Innovación, Leucemia, Hematología, and Medicina Personalizada | 1 | 0 | 1 | 18 |
 | Tagworks Pharmaceuticals Pioneer of Click-to-Release chemistry; designing more effective and safer systemic therapies Tagworks Pharmaceuticals is a precision oncology company using our proprietary Click-to-Release treatment platform to develop a new standard of care for patients suffering from solid tumors by targeting clinically validated tumor markers that so far have remained out of reach of current therapies. Our lead program, TGW101, is an antibody-drug conjugate (ADC) targeting TAG72, a non-internalizing protein found on the surface of many solid tumor cells. We are developing a pipeline of novel cancer treatments leveraging our Click-to-Release technology in a range of therapeutic modalities, including ADCs and targeted … Type: | 1 | 0 | 0 | 30 |
 | Glentham Life Sciences Ltd. The Chemical, Biochemical & Research Essentials Supplier. Glentham Life Sciences is a UK-headquartered supplier of fine chemicals, biochemicals and raw materials. We are focussed on delivering high quality, well-documented products for the Diagnostics, Pharmaceutical, Research and Custom Synthesis markets. Customer service is important to us. Unlike many of our competitors, we offer complete flexibility on packaging units and materials, scheduled deliveries and call-off orders, and delivery of stock products to most of Europe within 24 hours of receiving your order. Our key product ranges include Antibiotics, Amino Acids and derivatives, Carbohydrates and derivatives, Buffers and many more. Glentham Life Sciences … Type: | 0 | 0 | 0 | 17 |
 | Dicot Pharma AB Dicot is a pharmaceutical company focused on increasing well-being through innovations that enhance sexual health. Dicot is a pharmaceutical company focused on increasing quality of life and well-being through innovations that enhance sexual health. The company develops and manufactures medicines for the treatment of erectile dysfunction and premature ejaculation. The company's lead candidate, LIB-01, is in clinical stage of development. erectile dysfunction, biopharma, premature ejaculation, drug development, pharma, sexual health, lifestyle , drug discovery, lifestyle, drug discovery, drugs from nature, and biopharmaceutical Type: | 1 | 0 | 1 | 9 |
Startup